-+ 0.00%
-+ 0.00%
-+ 0.00%
Kymera Therapeutics To Announce Results From Its Phase 1 Clinical Trial Evaluating Single And Multiple-Ascending Doses Of KT-579 In Healthy Volunteers On October 29
Share
Listen to the news

Announcement as part of its previously scheduled third quarter 2026 financial results. The Company will host a video conference call and webcast at 8:30 a.m. ET that day.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending